Reduced Dose of Imatinib for Patients with Chronic Myeloid Leukemia and Low Body Surface Area

Case Reports| November 29 2007 Reduced Dose of Imatinib for Patients with Chronic Myeloid Leukemia and Low Body Surface Area Subject Area: Hematology , Oncology Seh Jong Park; Seh Jong Park Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar In Keun Choi; In Keun Choi Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Hee Yun Seo; Hee Yun Seo Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Hwa Jung Sung; Hwa Jung Sung Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Kyong Hwa Park; Kyong Hwa Park Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Seok Jin Kim; Seok Jin Kim Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Sang Cheul Oh; Sang Cheul Oh Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Jae Hong Seo; Jae Hong Seo Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Chul Won Choi; Chul Won Choi Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Byung Soo Kim; Byung Soo Kim Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Sang Won Shin; Sang Won Shin Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Yeul Hong Kim; Yeul Hong Kim Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Jun Suk Kim Jun Suk Kim Department of Internal Medicine, Division of Hematology/Oncology, College of Medicine, Korea University, Seoul, Korea Search for other works by this author on: This Site PubMed Google Scholar Acta Haematol (2008) 118 (4): 219–221. https://doi.org/10.1159/000111777 Article history Received: July 19 2007 Published Online: November 29 2007 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Seh Jong Park, In Keun Choi, Hee Yun Seo, Hwa Jung Sung, Kyong Hwa Park, Seok Jin Kim, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim; Reduced Dose of Imatinib for Patients with Chronic Myeloid Leukemia and Low Body Surface Area. Acta Haematol 1 January 2008; 118 (4): 219–221. https://doi.org/10.1159/000111777 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsActa Haematologica Search Advanced Search Article PDF first page preview Close Modal © 2006 S. Karger AG, Basel2007Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.